Indies Pharma adds $1-billion loan from NCB at higher cost, but profit rises

October 16, 2026
75 billion in capital, up from over 60 per cent a year earlier. The company retired a Sagicor bond at 7.0 per cent, and now carries a 9.5 per cent note from National Commercial Bank (NCB). The effect shows Revenue rose 12 per cent to $292.4...